Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sudapyridine (WX-081) in Pulmonary Tuberculosis
NCT04608955Phase 2Completed
- Sponsor
- Shanghai Jiatan Pharmatech
- Start
- Oct 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sudapyridine in pulmonary tuberculosis (TB), sponsored by Shanghai Jiatan Pharmatech. Started Oct 2020; status: completed.
02
Drugs
sudapyridine
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT04608955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04608955.